Advertisement
Screener

Valion Bio, Inc. (VBIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Valion Bio, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Valion Bio, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $7.00M went out.
  • Fiscal year ended 2025-12-31: from investing, $705.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $18.35M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.64M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$7.00M-$705.00K$2.34M$16.01M*$10.64M
2024-12-31-$5.72M$0.00$0.00$4.33M*-$1.39M
2023-12-31-$8.51M-$118.00K$8.51M-$122.00K
2022-12-31-$8.92M-$11.00K$56.00K-$584.00K*-$9.46M
2021-12-31-$5.61M$14.89M$2.66M*$11.93M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$5.28M*-$57.00K*
2026-03-31-$5.01M-$7.00K-$5.06M
2025-12-31-$2.29M*-$149.00K*$0.00*$11.63M*
2025-09-30-$2.00M*-$10.00K*$429.00K*$3.84M*
2025-06-30-$1.83M*-$20.00K*$2.36M*
2025-03-31-$889.00K-$526.00K-$1.33M
2024-12-31-$1.36M*$0.00*$0.00*$1.18M*
2024-09-30-$1.41M*-$3.25M*
2024-06-30-$1.29M*$3.31M*
2024-03-31-$1.67M-$1.73M
2023-12-31-$1.77M*$0.00*$0.00*
2023-09-30-$1.87M*$0.00*$4.32M*
2023-06-30-$2.44M*-$24.00K*$0.00*
2023-03-31-$2.43M-$94.00K$4.19M$1.65M
2022-12-31-$2.23M*$0.00*$0.00*-$584.00K*
2022-09-30-$2.77M*-$5.00K*
2022-06-30-$1.75M*$0.00*
2022-03-31-$2.17M-$6.00K-$2.17M
2021-12-31-$2.76M*$0.00*$14.89M*
2021-09-30-$1.64M*$56.00K*$813.00K*
2021-06-30-$543.00K*$0.00*$1.57M*
2021-03-31-$665.00K$6.00K-$444.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41